Skip to main content
Equibles

Paul Moore

Zymeworks Inc. (ZYME)

Equibles does not estimate personal net worth.

Get an email with a short summary when Zymeworks Inc. publishes a filing, an earnings call transcript or a press release.

Get ZYME alerts

About Paul Moore

The proxy statement of Zymeworks Inc. reports total compensation of $1,986,803 for Paul Moore in fiscal 2024, including a base salary of $494,683. Disclosed compensation is on record for 2 fiscal years. Paul Moore has spoken on 1 earnings call across 1 company, most recently for Zymeworks Inc. on March 2, 2026. Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

Paul Moore on recent calls

“Well, yeah, no. So PTK7 is a target that we've been very interested in. We see it pairing nicely with both TOPO and also with the RAS payload technology. There, PTK7 has an attractive tumor expression profile.”
Other, Zymeworks Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Zymeworks Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Zymeworks Inc. (ZYME) $494,683 $1,986,803
2023 Zymeworks Inc. (ZYME) $465,784 $1,682,237

Recent activity